Showing results (801-810 of 1,609) with videos related to

Sort By:
Pageof 161
JAMA Oncology|January 27, 2018
Comparison Between Adjuvant and Early-Salvage Postprostatectomy Radiotherapy for Prostate Cancer With Adverse Pathological FeaturesWilliam L Hwang, Rahul D Tendulkar, Andrzej Niemierko, et al.
JAMA Oncology|March 30, 2018
Patterns in Health Care Access and Affordability Among Cancer Survivors During Implementation of the Affordable Care ActRyan D Nipp, Amy M Shui, Giselle K Perez, et al.
JAMA Oncology|February 10, 2018
Atezolizumab (MPDL3280A) Monotherapy for Patients With Metastatic Urothelial Cancer: Long-term Outcomes From a Phase 1 StudyDaniel P Petrylak, Thomas Powles, Joaquim Bellmunt, et al.
JAMA Oncology|February 23, 2018
Defining the Most Appropriate Primary End Point in Phase 2 Trials of Immune Checkpoint Inhibitors for Advanced Solid Cancers: A Systematic Review and Meta-analysisGeorgia Ritchie, Harry Gasper, Johnathan Man, et al.
JAMA Oncology|February 23, 2018
Prognostic Factors for Complete Response to Ibrutinib in Patients With Chronic Lymphocytic Leukemia: A Pooled Analysis of 2 Clinical TrialsSusan M O'Brien, Samantha Jaglowski, John C Byrd, et al.
JAMA Oncology|February 17, 2018
Effect of Neoadjuvant Chemotherapy Plus Regional Hyperthermia on Long-term Outcomes Among Patients With Localized High-Risk Soft Tissue Sarcoma: The EORTC 62961-ESHO 95 Randomized Clinical TrialRolf D Issels, Lars H Lindner, Jaap Verweij, et al.
JAMA Oncology|February 17, 2018
Pediatric-Inspired Treatment Regimens for Adolescents and Young Adults With Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia: A ReviewStuart E Siegel, Wendy Stock, Rebecca H Johnson, et al.
JAMA Oncology|December 2, 2017
Association of Quantitative Metastatic Lymph Node Burden With Survival in Hypopharyngeal and Laryngeal CancerAllen S Ho, Sungjin Kim, Mourad Tighiouart, et al.
JAMA Oncology|October 5, 2017
Adjuvant Chemotherapy vs Postoperative Observation Following Preoperative Chemoradiotherapy and Resection in Gastroesophageal Cancer: A Propensity Score-Matched AnalysisAli A Mokdad, Adam C Yopp, Patricio M Polanco, et al.
JAMA Oncology|October 7, 2017
Role of Deficient DNA Mismatch Repair Status in Patients With Stage III Colon Cancer Treated With FOLFOX Adjuvant Chemotherapy: A Pooled Analysis From 2 Randomized Clinical TrialsAziz Zaanan, Qian Shi, Julien Taieb, et al.
Pageof 161